Osterweis Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-89,726
| Closed | -$7.6M | – | 111 |
|
|
2018
Q4 | $7.6M | Buy |
89,726
+42,383
| +90% | +$3.59M | 0.58% | 52 |
|
|
2018
Q3 | $8.11M | Buy |
47,343
+192
| +0.4% | +$32.9K | 0.52% | 58 |
|
|
2018
Q2 | $6.09M | Sell |
47,151
-19,524
| -29% | -$2.52M | 0.39% | 55 |
|
|
2018
Q1 | $6.87M | Buy |
66,675
+11,173
| +20% | +$1.15M | 0.49% | 46 |
|
|
2017
Q4 | $4.74M | Sell |
55,502
-8,216
| -13% | -$702K | 0.34% | 48 |
|
|
2017
Q3 | $5.41M | Buy |
63,718
+1,155
| +2% | +$98.1K | 0.41% | 43 |
|
|
2017
Q2 | $4.74M | Buy |
62,563
+13,545
| +28% | +$1.03M | 0.36% | 43 |
|
|
2017
Q1 | $3.24M | Sell |
49,018
-12,407
| -20% | -$819K | 0.25% | 54 |
|
|
2016
Q4 | $3.89M | Buy |
+61,425
| New | +$3.89M | 0.28% | 46 |
|